Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew Simonson, JoAnne L. Flynn, Forrest Hopkins et al.|The Journal of Experimental Medicine|2025Cited by 34
A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicityAlexander A. Smith, JoAnne L. Flynn, Philana Ling Lin et al.|Nature Microbiology|2025Cited by 10